NasdaqCM - Delayed Quote USD

Check-Cap Ltd. (CHEK)

Compare

0.7745

-0.0455

(-5.55%)

At close: November 15 at 4:00 PM EST

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2023

12/31/2022

12/31/2021

12/31/2020

Operating Expense

17,767.0000

19,997.0000

17,299.0000

13,904.0000

Operating Income

-17,767.0000

-19,997.0000

-17,299.0000

-13,904.0000

Net Non Operating Interest Income Expense

1,757.0000

1,035.0000

88.0000

57.0000

Other Income Expense

-1,558.0000

-146.0000

9.0000

1.0000

Pretax Income

-17,568.0000

-19,108.0000

-17,202.0000

-13,846.0000

Net Income Common Stockholders

-17,568.0000

-19,108.0000

-17,202.0000

-13,846.0000

Diluted NI Available to Com Stockholders

-17,568.0000

-19,108.0000

-17,202.0000

-13,846.0000

Basic EPS

-3.00

-3.37

-4.20

-9.20

Diluted EPS

-3.00

-3.37

-4.20

-9.20

Basic Average Shares

5,848.7370

5,671.7860

4,140.3770

1,517.5500

Diluted Average Shares

5,848.7370

5,671.7860

4,140.3770

1,517.5500

Total Operating Income as Reported

-19,287.0000

-20,034.0000

-17,321.0000

-13,932.0000

Rent Expense Supplemental

235.0000

246.0000

172.0000

174.0000

Total Expenses

17,767.0000

19,997.0000

17,299.0000

13,904.0000

Net Income from Continuing & Discontinued Operation

-17,568.0000

-19,108.0000

-17,202.0000

-13,846.0000

Normalized Income

-16,010.0000

-18,962.0000

-17,211.0000

-13,847.0000

Interest Income

1,770.0000

1,047.0000

101.0000

69.0000

Interest Expense

13.0000

12.0000

13.0000

12.0000

Net Interest Income

1,757.0000

1,035.0000

88.0000

57.0000

EBIT

-17,555.0000

-19,096.0000

-17,189.0000

-13,834.0000

EBITDA

-17,343.0000

-18,692.0000

-16,984.0000

-13,686.0000

Reconciled Depreciation

212.0000

404.0000

205.0000

148.0000

Net Income from Continuing Operation Net Minority Interest

-17,568.0000

-19,108.0000

-17,202.0000

-13,846.0000

Total Unusual Items Excluding Goodwill

-1,558.0000

-146.0000

9.0000

1.0000

Total Unusual Items

-1,558.0000

-146.0000

9.0000

1.0000

Normalized EBITDA

-15,785.0000

-18,546.0000

-16,993.0000

-13,687.0000

12/31/2020 - 3/4/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

BIM.PA bioMérieux S.A.

97.60

-0.76%

NDRA ENDRA Life Sciences Inc.

4.5400

-14.34%

PRPH ProPhase Labs, Inc.

0.7500

-0.19%

TTOO T2 Biosystems, Inc.

0.4970

-4.42%

CDNA CareDx, Inc

21.17

-1.76%

HTGMQ HTG Molecular Diagnostics, Inc.

0.0003

0.00%

STIM Neuronetics, Inc.

0.7100

-10.13%

ISPC iSpecimen Inc.

4.2000

-3.45%

PRPO Precipio, Inc.

6.19

-0.77%

ERF.PA Eurofins Scientific SE

45.61

+0.37%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Check-Cap Ltd. (CHEK)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers